Non-tuberculous mycobacterial (NTM) diseases usually affect individuals with compromised immune systems. However, a recent case study describes a 49-year-old immunocompetent man who developed a severe Mycobacterium genavense infection. This rare pathogen typically presents in HIV-positive patients, making its appearance in a healthy adult particularly unusual for clinicians.

Diagnostic Challenges and Mimicry of Malignancy

The patient initially reported persistent respiratory symptoms. Consequently, the medical team performed thoracic imaging, which revealed a hilar mass and mediastinal lymphadenopathy. Because these findings strongly suggested lung cancer, the patient underwent a rigorous diagnostic workup. Ultimately, molecular diagnostics bypassed the limitations of traditional cultures. These advanced tests identified M. genavense as the underlying cause of the patient’s symptoms.

Treating Mycobacterium genavense infection in Healthy Adults

Managing this rare condition requires a highly specific and prolonged antibiotic approach. In this instance, the clinicians prescribed a 15-month regimen. This therapy included a combination of rifampicin, azithromycin, and ethambutol. Furthermore, the patient adhered strictly to the treatment plan. As a result, he achieved complete clinical and radiological remission, highlighting the effectiveness of macrolide-based strategies even in immunocompetent hosts.

In conclusion, clinicians should consider NTM species even in patients without obvious immune deficiencies. While imaging might suggest malignancy, molecular tools remain essential for an accurate diagnosis. Timely intervention with appropriate multidrug therapy ensures favorable outcomes and prevents unnecessary oncological treatments.

Frequently Asked Questions

How does Mycobacterium genavense typically present?

It most often causes disseminated disease in immunocompromised patients, presenting with fever, weight loss, and gastrointestinal symptoms. In rare pulmonary cases, it can mimic tuberculosis or lung cancer.

Why is molecular diagnostics necessary for this pathogen?

M. genavense is extremely fastidious and grows slowly in standard liquid media. Therefore, PCR and 16S rRNA gene sequencing are often the only ways to confirm the diagnosis quickly.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

• Früh J et al. [Severe pulmonary Mycobacterium genavense infection in an immunocompetent adult : Diagnostic challenges and successful macrolide-based combination therapy]. Inn Med (Heidelb). 2026 Mar 26. doi: 10.1007/s00108-026-02097-2. PMID: 41886077.


• Nurul Yaqeen et al. A Rare and Challenging Case of Pulmonary Mycobacterium genavense in an Immunocompetent Adult. JCHS. 2018;3(1):47-50.


• Daley CL et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Eur Respir J. 2020;56(1):2000535.